Abstract
The HIV-1 Rev protein, which traffics through nucleolus and shuttles between nucleus and cytoplasm, facilitates export of unspliced and singly spliced viral transcripts containing RRE RNA by the CRM1 export pathway. Inhibitions of the various stages of Rev-mediated RNA transport can arrest HIV-1 transcriptional process. The current understanding to the mechanism of Rev function, Rev-RRE interaction, as well as inhibitors hereof is reviewed.
Keywords: AIDS, HIV-1, transcription, inhibitors, Rev, RRE, antiviral
Current HIV Research
Title: Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev- Mediated RNA Transport
Volume: 7 Issue: 1
Author(s): Yuan Cao, Xinyong Liu and Erik De Clercq
Affiliation:
Keywords: AIDS, HIV-1, transcription, inhibitors, Rev, RRE, antiviral
Abstract: The HIV-1 Rev protein, which traffics through nucleolus and shuttles between nucleus and cytoplasm, facilitates export of unspliced and singly spliced viral transcripts containing RRE RNA by the CRM1 export pathway. Inhibitions of the various stages of Rev-mediated RNA transport can arrest HIV-1 transcriptional process. The current understanding to the mechanism of Rev function, Rev-RRE interaction, as well as inhibitors hereof is reviewed.
Export Options
About this article
Cite this article as:
Cao Yuan, Liu Xinyong and De Clercq Erik, Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev- Mediated RNA Transport, Current HIV Research 2009; 7 (1) . https://dx.doi.org/10.2174/157016209787048564
DOI https://dx.doi.org/10.2174/157016209787048564 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Expression Under the Influence: Transcriptional Profiling of Ethanol in the Brain
Current Psychopharmacology Depression, Antidepressants and Hypertensive Disorders of Pregnancy: A Systematic Review
Current Drug Safety The AKT Axis as a Therapeutic Target in Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Reduced Alzheimer’s Disease Pathology by St. John’s Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice
Current Alzheimer Research Preface:
Central Nervous System Agents in Medicinal Chemistry PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
Current Pharmaceutical Design Immunotherapy of Kidney Cancer
Current Clinical Pharmacology Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Current Vascular Pharmacology Impact of Covid-19 on Mental Health: An Overview
Reviews on Recent Clinical Trials Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients
CNS & Neurological Disorders - Drug Targets Schizophrenia Patient Shows a Rare Interleukin 15 Receptor alpha Variant Disrupting Signal Transduction
Current Molecular Medicine The Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins
Current Drug Targets From the Editors Perspective: Aquaporins to Apoptosis
Current Neurovascular Research Three-Component Efficient Synthesis of 2-Amino-3-cyano-4H-pyrans Catalyzed by Diammonium Hydrogen Phosphate in Aqueous Media
Current Organocatalysis Atmospheric Prebiotic Chemistry and Organic Hazes
Current Organic Chemistry Curcumin Prevents Neuroinflammation by Inducing Microglia to Transform into the M2-phenotype via CaMKKβ-dependent Activation of the AMP-Activated Protein Kinase Signal Pathway
Current Alzheimer Research Mechanisms and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Cerium Oxide Nanoparticles Trigger Neuronal Survival in a Human Alzheimer Disease Model By Modulating BDNF Pathway
Current Nanoscience Substance Use Portrayal in Oscar-nominated Movies
Current Drug Research Reviews Meet Our Editorial Board Member
Current Alzheimer Research